# Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy

> **NCT07567313** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 166 (estimated)

## Conditions studied

- Lung Squamous Cell Carcinoma Stage IV

## Interventions

- **PROCEDURE:** Immunotherapy combined with interventional therapy group
- **DRUG:** Immunotherapy group

## Key facts

- **NCT ID:** NCT07567313
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-06-30
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07567313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07567313, "Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07567313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*